Lucía Pérez-Lamas

6PUBLICATIONS
48CO-AUTHORS
Haematological tumoursMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 04, 2026
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.

|May 16, 2023
Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination.

Sara Rodríguez-Mora, Lucía Pérez-Lamas, Miriam Solera Sainero

|Feb 25, 2023
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors.

Lucía Pérez-Lamas, Alejandro Luna, Concepción Boque

|Apr 23, 2022
Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection.

Lorena Vigón, Adrián Sánchez-Tornero, Sara Rodríguez-Mora

Pageof 1

Frequent Collaborators

5 joint publications

Valentín García-Gutiérrez

3 joint publications

Juan-Carlos Hernández-Boluda

3 joint publications

Manuel Pérez-Encinas

2 joint publications

Sara Rodríguez-Mora